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Introduction
Systemic-onset juvenile idiopathic arthritis (s-JIA), also 
called Still’s disease, systemic-onset juvenile chronic ar-
thritis (s-JCA), or systemic-onset juvenile rheumatoid ar-
thritis (s-JRA) is not a single disease but a term that 
encompasses all forms of arthritis that begin before the 
age of 16, persist for more than 6 weeks, and are of un-
known cause (according to the 1986 definition criteria).1,2 
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BACKGROUND/PURPOSE: Systemic-onset juvenile idiopathic arthritis (s-JIA) is a systemic disease 
often accompanied by a fever. We examined 16 patients with s-JIA and reported the clinical manifesta-
tions, laboratory data, treatments and outcomes.
METHODS: From 1984 to 2007, 16 children (aged 1–16 years), who were diagnosed as having s-JIA, were 
admitted to the Mackay Memorial Hospital in Taiwan. We retrospectively reviewed their medical charts.
RESULTS: There were nine boys and seven girls, with mean age of onset of 7.4 ± 5.5 years. Fever (100%), 
typical rash (63%), and arthritis (75%) were the three most common symptoms. Lymphadenopathy (50%), 
hepatosplenomegaly (63%), pleural pulmonary manifestations (13%) and myalgia (25%) were also noted. 
One patient had Epstein-Barr virus-associated hemophagocytic syndrome complications. Neutrophilic 
leukocytosis was a common feature. Other laboratory data showed elevated C-reactive protein levels 
(25.1 ± 50.3 mg/dL), and erythrocyte sedimentation rates (69 ± 28 mm/hr) and abnormal liver enzymes. 
Marked hyperferritinemia (> 2,000 ng/mL) was noted in 57% (4/7) of the patients. The mean time from 
onset of symptoms to diagnosis was 9.2 weeks. Non-steroidal anti-inflammatory drugs, steroids, disease-
modifying anti-rheumatic drugs and anti-tumor necrosis factor agents were used for treatment. Due to 
prolonged fever, 2.0 ± 1.6 (maximum = 5) different kinds of antibiotics were used before a diagnosis was made. 
Most cases had satisfactory therapeutic outcomes except one boy, who had permanent joint contracture.
CONCLUSION: The clinical manifestations of s-JIA in Taiwan were often accompanied by a prolonged 
fever. This results in clinicians often suspecting bacterial infections and prescribing several kinds of antibi-
otics. In the case of prolonged fever, s-JIA should always be placed on the list of differential diagnoses.
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We used to think of joints when we mentioned JIA but, in 
fact, many s-JIA cases are accompanied by a prolonged 
fever. Now, this definition is currently being supplanted 
by the newer International League of Associations for 
Rheumatology criteria, which more strictly defines the 
quotidian nature of the fever and requires the presence of 
at least one of the other four characteristic systemic signs: 
rash, generalized lymphadenopathy, organomegaly, or se-
rositis.3 Since the disease is mainly diagnosed by clinical 
criteria and by exclusion, recognition of the clinical symp-
toms and signs is important. Much literature regarding 
the disease has been published in the Western countries. 
A recent study evaluated the presentation of s-JRA in 
Pennsylvania.4
In Taiwan, one clinical manifestation of adult-onset 
Still’s disease was reported in 2004.5 There were three 
other articles published; but none emphasized the clinical 
manifestrations.6–8 The clinical characteristics of JIA in 
Taiwan were reported in 1984,9 199310 and 2001,11 but no 
recent clinical observation data has been reported. Thus, 
we collected 16 cases and reviewed the clinical features of 
their presentation.
A prolonged high fever was the most common feature 
of s-JIA, but was often misdiagnosed as a bacterial infec-
tion. Thus, many unnecessary antibiotics were used. To 
avoid the abuse of antibiotics in future cases, we report 
the clinical characteristics of 16 cases of s-JIA.
Methods
From 1984 to 2007, 16 children (aged 1–16 years) were ad-
mitted to the Mackay Memorial Hospital. They were diag-
nosed as having s-JIA according to the 1986 definition 
criteria, or the International League of Associations for 
Rheumatology criteria. Their medical charts were retrospec-
tively reviewed, and gender, age, clinical manifestations, 
physical findings, laboratory data, image studies, treat-
ments, and prognosis were all analyzed. This data were col-
lected from medical records on their first admission.
Results
Clinical manifestations
Sixteen patients were enrolled in our study. There were 
nine boys and seven girls, with a mean age of onset of 
7.4 ± 5.5 years (ranging from 10 to 202 months). The mean 
time from onset of symptoms until diagnosis was 9.2 weeks 
(ranging from less than 1 week to almost 1 year). The clin-
ical manifestations of the patients diagnosed with s-JIA 
are shown in Table 1. According to the medical charts, the 
Aunt’s of both Case 3 and Case 13 had arthritis and the 
sister of Case 15 had human herpesvirus 6-related infantile 
rheumatoid arthritis when she was 12 years old.
Fever, rash, and arthritis were the three most common 
symptoms. All patients (16/16) had fever. The mean fever 
duration was 28.6 days, (ranging from 10 to 90 days) with 
a temperature of 39–40ºC. The typical rash was an eva-
nescent, non-fixed erythematosus rash and characteristi-
cally coincided with the fever peak.2 Sixty-three percent 
(10/16) of the patients displayed the typical rash. Arthritis 
is often symmetrical and polyarticular, and may be absent 
at onset but develop during the course of the disease.2 Our 
findings are consistent with previous reports in that the 
knee, ankle, wrist, proximal interphalangeal, and distal 
interphalangeal joints were the most commonly involved 
joints in s-JIA patients.11
Seventy-five percent (12/16) of the patients had arthri-
tis (red, swelling, local heat and tenderness). Four patients 
lacked sufficient data in their retrospective medical charts. 
The most common sign was swelling and only one patient 
had morning stiffness. Polyarthritis accounted for 31% 
(5/16) of cases and oligoarthritis accounted for 44% (7/
16). The knee joint was the most commonly affected site 
(4/12), with the ankle joint ranked second (2/12). Unlike 
previous studies that indicated significant morbidity in 
children with s-JIA in Taiwan,12 most of our patients had 
a good prognosis; permanent joint contracture and dis-
ability were noted in only one patient (1/16, 0.6%; Case 4).
A sore throat is characteristic of adult-onset Still’s dis-
ease, but was not the main criterion for s-JIA.13,14 In the 
three patients who had a sore throat, the local findings 
revealed an infected throat without exudates.
Of the sixteen cases, lymphadenopathy was present in 
eight patients (50%). Cervical and axillary areas were the 
most commonly affected sites. Most of the lymphade-
nopathies were larger than 1 cm. The largest was 2 × 2 × 
1 cm. One patient (Case 16) had a right auxiliary lymph 
node biopsy performed that showed only reactive hyper-
plasia. Hepatosplenomegaly (2–3 fingerbreadths below the 
right costal margin) was seen in 62.4% (10/16) of patients. 
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Myalgia was recorded in 4/16 cases (25%). Two patients 
(2/16, 12.5%) had pleural pulmonary manifestations, such 
as pleural and pericardial effusion.
Bacterial, or viral, infections such as Mycoplasma 
pneumoniae might have had a role in triggering JIA.15 Of 
our cases, four patients had M. pneumoniae. One patient 
(Case 2) had Epstein-Barr virus-associated hemophago-
cytic syndrome (EBV-VAHS) complications.
Laboratory data
The laboratory results are summarized in Table 2. Neu-
trophilic leukocytosis was a common feature. White 
blood counts ranged from 3,500/μL to 44,000/μL (mean = 
15,932 ± 10,872/μL). Hemoglobin was 10.5 ± 1.2 g/dL. The 
mean platelet count was 459 ± 234 × 103/μL (range, 91–
804 × 103/μL). Other laboratory data revealed elevated 
C-reactive proteins (25.1 ± 50.3 mg/dL; ranging from 
0.01mg/dL to 200 mg/dL), and erythrocyte sedimentation 
rates (69 ± 28 mm/hr). Impaired liver function was also 
noted. Glutamate oxaloacetate transaminase was 69 ± 
53 IU/L (ranging from 20 IU/L to 169 IU/L). Glutamic 
pyruvic transaminase was 34.6 ± 35.2 IU/L (ranging from 
12 IU/L to 123 IU/L).
Ferritin levels were checked in 10 patients. The mean 
value for ferritin was 21,061 ng/mL. Markedly hyper-
ferritinemia (> 2,000 ng/mL) was noted in 57% (4/7).
Antinuclear antibody titers were checked in 13 pa-
tients. Four were negative (31%), seven patients (54%) had 
a low titer (≤ 1:80). Of the two patients whose antinuclear 
antibody titer was higher than 1:80, all had the speckled 
form. Rheumatoid factor was negative in all except one 
patient, who had a rheumatoid factor titer of 48.7 IU/mL. 
Human leukocyte antigen-B27 (HLA-B27) was checked in 
four patients and only one was positive (25%). Anti-cyclic 
citrullinated peptide was checked in Case 16 and the 
result was negative.
C3 and C4 did not decrease. The mean serum C3 con-
centration was 163 ± 40 mg/dL (ranging from 86 mg/dL to 
206 mg/dL; normal range, 79–152 mg/dL). The mean se-
rum C4 concentration was 31 ± 10.4 mg/dL (ranging from 
19 mg/dL to 54 mg/dL; normal range, 16–38 mg/dL).
Imaging studies and invasive procedures such as ab-
dominal echogram, computed tomography, magnetic res-
onance imaging, bone marrow biopsy and Gallium scan 
were also performed. Most of the examinations were non-
diagnostic, or yielded negative results, except that one 
Table 2. Laboratory data of patients with systemic-onset juvenile idiopathic arthritis
Case
 Hb WBC Neut  Platelet CRP ESR GOT GPT Ferritin ANA  RF C3/C4
 (g/dL) (μL) (%) (103/μL) (mg/dL) (mm/hr) (IU/L) (IU/L) (ng/mL) (< 40 × +) (IU/mL) (mg/dL)
 1 9.3 31,100 85 536 –  60 169 123 – – < 20 160/33
 2 9.6 11,700 67  91 7.54 – 143  49  5,530 – < 20 193/99
 3 8.8 27,900 86 556 32.30  64  46  13 – – < 20 155/31
 4 8.4 22,100 82 623 200.00  70  72  20 – – neg –/–
 5 9.0 18,000 72 804 12.06  81 – –   257  80 < 30 206/22
 6 11.8  4,900 49 247 1.69  26  29  15 –  80 < 20 86/19
 7 10.6 44,000 82 758 5.29  50 – –   480  40 < 20 –/–
 8 11.2 11,100 53 699 5.78 107  20  18   125 – < 20 205/–
 9 10.9 11,800 65 619 26.50  6 – – –  80 < 20 192/54
10 12.0 14,400  7 642 6.95 113 – – – – < 20 –/–
11 12.5  3,500 45 154 0.01  61 – – – 640 48.7 116/25
12 11.2  9,800 42 – 45.00  81 – – – 320 neg 154/–
13 10.7 16,300 92 325 11.00  87  69  33 132,222  40 < 20 158/20
14 10.9 15,800 83 254 11.20  99  39  28  4,814  40 < 20 208/33
15 9.8 8,210 67 350 4.58  60 – – – – < 20 –/–
16 11.2 4,300 67 232 2.00  66  35  12  4,002  40 < 20 124/31
Hb = Hemoglobin; WBC = white blood cell; Neut = neutrophils; CRP = C-reactive protein; ESR = erythrocyte sedimentation rates; GOT = glutamate 
oxaloacetate transaminase; GPT = glutamic pyruvic transaminase; ANA = antinuclear antibody; RF = rheumatoid factor; neg = negative.
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patient (Case 8) had a thoracic spinal lesion which was 
revealed in a bone scan, a Gallium scan and a spinal mag-
netic resonance imaging. Previous reports often mention 
the relationship between the cervical spine and JIA,16,17 
but none mention the thoracic spine.
Treatment
One of the 16 patients (6.3%) received acetaminophen, and 
five patients (31.3%) received aspirin (dose, 80–100 mg/kg/
day) before the diagnosis was made. Due to a poor response, 
non-steroidal anti-inflammatory drugs (NSAIDs) were 
also given to 13 patients (81.3%). The most common NSAID 
was naproxen (12/13, 92.3%). Steroids were also added to 
the treatment regimen if NSAIDs failed, and accounted 
for 75.0% (12/16) of patients. Steroid was administered in 
different ways. An oral steroid (11/12, 91.7%) was the most 
common, although systemic steroids (5/12, 41.7%) or even 
pulse therapy (2/12, 16.7%) was also used. Nineteen per-
cent (3/16) of patients received disease-modifying anti-
rheumatic drugs. Most of them were given sulfasalazine, 
hydroxychloroquine and methotrexate. Only Case 3 (1/16) 
received an anti-tumor necrosis factor agent (etanercept). 
Most cases showed satisfactory therapeutic outcomes. Only 
one boy was left with permanent joint contracture. Because 
one patient had EBV-VAHS complications, intravenous 
immunoglobulin and chemotherapy were given.
Antibiotics, due to prolonged fever, were used empiri-
cally for covering unknown bacterial infections. The mean 
period of antibiotic usage was 7.3 ± 6.5 days (range, 1–18 
days), and 2.0 ± 1.6 (maximum = 5) kinds of antibiotics were 
used before a diagnosis was made.
Discussion
s-JIA can be difficult to diagnose due to the lack of specific 
biomarkers, variable presentations, and overlap of symp-
toms with many other illnesses.
The main limitation of the present study resides in 
its retrospective design. Furthermore, our analysis was 
conducted on a limited number of patients. We were able 
to record a limited number of clinical histories and labo-
ratory data, and this weakened the significance of our sta-
tistical analysis.
Our clinical findings are consistent with a report on 
a cohort of patients from the United Kingdom, France, 
and Spain18 and a recent retrospective report from 
Pennsylvania.4 In short, the clinical manifestations of 
s-JIA in Taiwan are similar to those reported worldwide.
In our study, the male to female ratio was 9:7. The pre-
vious studies did not find any significant sex bias for 
s-JIA.19 The time between onset of symptoms until diag-
nosis indicates that the disease is difficult to diagnose in 
the beginning if we do not keep the diagnosis and clinical 
features in mind. Also, myalgia and abdominal pain can 
be intense during fever peaks.
The results of our laboratory investigations are similar 
to those of previous studies, such as neutrophilic leukocy-
tosis, high erythrocyte sedimentation rates, high C-reactive 
proteins, thrombocytosis and microcytic anemia.2 The se-
rology for atypical or viral infections were all negative, in-
cluding serology for EBV, cytomegalovirus, mycoplasma, 
scrub typhus, Lyme disease, malaria, Q fever and typhoid 
fever. Thrombocytopenia and abnormal bone marrow 
changes, such as megakaryocytic or erythroid hyperplasia 
have been reported in Taiwan, but were not observed in 
our study.20
Macrophage activation syndrome (MAS), or hemo-
phagocytic syndrome, is a severe complication of chronic 
rheumatic diseases, especially s-JIA.21 The frequency of 
MAS in s-JIA was found in one retrospective study from a 
tertiary pediatric rheumatology unit to be 6.7%.22 Patients 
usually present with an acute febrile illness, hepatospleno-
megaly, lymphadenopathy, cutaneous and mucosal bleed-
ing, pancytopenia, and central nervous system, cardiac, 
and renal involvement.21 MAS is often difficult to recog-
nize because the symptoms and signs are the same as those 
of active s-JIA. The differences between MAS and s-JIA are 
discussed in another article.23
NSAIDs have been the mainstay of treatment of s-JIA 
for decades. Intra-articular steroid injections of triam-
cinolone hexacetonide, moderate or high-dose systemic 
corticosteroid therapy, anti-tumor necrosis factor agents, 
physiotherapy, and occupational therapy are the main-
stream treatments for s-JIA.2
Due to the common initial presentation of a fever of 
unknown origin and elevated systemic inflammatory lab-
oratory profiles, serial workup and other examinations 
are often done to include or exclude possible infectious 
pathogens. Thus, many unnecessary antibiotics are given 
for non-infectious, rheumatological diseases. Several kinds 
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of antibiotics are used for 1–2 months on average. The cost, 
adverse effects, and possible production of resistant strains 
are all concerns with unnecessary antibiotic treatment. 
Earlier diagnosis reduces unnecessary antibiotic use.
In conclusion, the clinical manifestations of s-JIA in 
Taiwan often present alongside a prolonged fever, which 
causes clinicians to assume bacterial infections are present 
and to prescribe several kinds of antibiotics. In cases of 
prolonged fever, s-JIA should always be put on the list of 
differential diagnoses to avoid abuse of antibiotics.
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